top of page

Publications

Original Article

Antigen-specific recall urticaria to a peptide-based vaccine

Cancer Vaccines

1999

Authors:

Rinn K, Schiffman K, Otero HO and Disis ML

Journal:

Journal of Allergy and Clinical Immunology

Volume:

104(1)

Page:

240-2

Pubmed:

Original Article

Antibody immunity to the HER-2/neu oncogenic protein in patients with colorectal cancer

Cancer Vaccines

1999

Authors:

Ward RL, Hawkins NJ, Coomber D, Disis ML

Journal:

Human Immunology

Volume:

60(6)

Page:

510-5

Pubmed:

Original Article

Human HER-2/neu protein immunization circumvents tolerance to rat neu: a vaccine strategy for 'self' tumour antigens

Clinical Trials

1998

Authors:

Disis ML, Shiota FM and Cheever MA

Journal:

Immunology

Volume:

93(2)

Page:

192-9

Pubmed:

Original Article

Immunization of metastatic breast cancer patients with CD80-modified breast cancer cells and GM-CSF

Clinical Trials

1998

Authors:

Schoof DD, Smith JW 2nd, Disis ML, Brant-Zawadski P, Wood W, Doran T, Johnson E Ubra WJ

Journal:

Gene Therapy of Cancer

Volume:

451

Page:

511-8

Pubmed:

Original Article

Identification of Her-2/Neu CTL epitopes using double transgenic mice expressing HLA-A2.1 and human CD.8

Cancer Vaccines

1997

Authors:

Lustgarten J, Theobald M, Labadie C, LaFace D, Peterson P, Disis ML, Cheever MA and Sherman LA

Journal:

Human Immunology

Volume:

52(2)

Page:

109-18

Pubmed:

Original Article

High-titer HER-2/neu protein-specific antibody can be detected in patients with early-stage breast cancer

Cancer Vaccines

1997

Authors:

Disis ML, Pupa SM, Gralow JR, Dittadi R, Menard S and Cheever MA

Journal:

Journal of Clinical Oncology

Volume:

15(11)

Page:

3363-7

Pubmed:

Original Article

Peptide-based, but not whole protein, vaccines elicit immunity to HER-2/neu, oncogenic self-protein

Cancer Vaccines

1996

Authors:

Disis ML, Gralow JA, Bernhard H, Hand SL, Rubin WD, Cheever MA

Journal:

Journal of Immunology

Volume:

156(9)

Page:

3151-8

Pubmed:

Original Article

Granulocyte-macrophage colony-stimulating factor: an effective adjuvant for protein and peptide-based vaccines

Cancer Vaccines

1996

Authors:

Disis ML, Bernhard H, Shiota FM, Hand SL, Gralow JR, Huseby ES, Gillis S and Cheever MA

Journal:

Blood

Volume:

88(1)

Page:

202-10

Pubmed:

Original Article

CD4+ T-cell immunity to mutated ras protein in pancreatic and colon cancer patients

Cancer Vaccines

1995

Authors:

Qin H, Chen W, Takahashi M, Disis ML, Byrd DR, McCahill L, Bertram KA, Fenton RG, Peace DJ, Cheever MA.

Journal:

Cancer Research

Volume:

55(14)

Page:

2984-7

Pubmed:

Original Article

Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral blood

Tumor Microenvironment

1995

Authors:

Bernhard H, Disis ML, Heimfeld S, Hand S, Gralow JR and Cheever MA

Journal:

Cancer Research

Volume:

55(5)

Page:

1099-104

Pubmed:

bottom of page